Literature DB >> 6312681

The effect of poliovirus infection on the translation in vitro of VSV messenger ribonucleoprotein particles.

C L Jones, E Ehrenfeld.   

Abstract

Messenger ribonucleoprotein (mRNP) particles were isolated and examined for the presence of factors involved in the inhibition of protein synthesis induced by poliovirus infection. Vesicular stomatitis virus (VSV) mRNPs were used as a model for cellular mRNPs. These mRNPs were translated in HeLa cell extracts with a similar efficiency and optimal conditions to that of purified mRNA, but they were not translated in extracts prepared from poliovirus-infected HeLa cells, which have been shown to be defective in cap-binding protein activity. We conclude that mRNP proteins do not include cap-binding protein activity, since the mRNPs were not able to bypass the restriction on translation of capped mRNAs in polio-infected cell extracts. In addition, VSV mRNPs were isolated from polio-superinfected cells, in which their translation was inhibited. These mRNPs were translated in vitro as well as normal VSV mRNPs. No evidence of a modification or a blocking factor on the mRNPs which prevented their translation following polio infection was observed. Thus, within the limits of the in vitro translation assays used, no factors involved in the discrimination between polioviral and cellular or VSV mRNA could be detected in the mRNP particle.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6312681     DOI: 10.1016/0042-6822(83)90180-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Poliovirus unlinks TIA1 aggregation and mRNA stress granule formation.

Authors:  James P White; Richard E Lloyd
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Cleavage of eukaryotic initiation factor eIF5B by enterovirus 3C proteases.

Authors:  Sylvain de Breyne; Jennifer M Bonderoff; Konstantin M Chumakov; Richard E Lloyd; Christopher U T Hellen
Journal:  Virology       Date:  2008-06-24       Impact factor: 3.616

3.  Identification and characterization of the cell surface 70-kilodalton sialoglycoprotein(s) as a candidate receptor for encephalomyocarditis virus on human nucleated cells.

Authors:  Y M Jin; I U Pardoe; A T Burness; T I Michalak
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

4.  Multiple eIF4GI-specific protease activities present in uninfected and poliovirus-infected cells.

Authors:  Miguel Zamora; Wilfred E Marissen; Richard E Lloyd
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  The outcome of poliovirus infections in K562 cells is cytolytic rather than persistent after hemin-induced differentiation.

Authors:  P A Benton; D J Barrett; R L Matts; R E Lloyd
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  mRNA decapping enzyme 1a (Dcp1a)-induced translational arrest through protein kinase R (PKR) activation requires the N-terminal enabled vasodilator-stimulated protein homology 1 (EVH1) domain.

Authors:  Jonathan D Dougherty; Lucas C Reineke; Richard E Lloyd
Journal:  J Biol Chem       Date:  2013-12-31       Impact factor: 5.157

7.  Restriction of translation of capped mRNA in vitro as a model for poliovirus-induced inhibition of host cell protein synthesis: relationship to p220 cleavage.

Authors:  R E Lloyd; H G Jense; E Ehrenfeld
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

8.  Poliovirus protease does not mediate cleavage of the 220,000-Da component of the cap binding protein complex.

Authors:  R E Lloyd; D Etchison; E Ehrenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

9.  Interaction of mRNA with proteins in vesicular stomatitis virus-infected cells.

Authors:  S A Adam; Y D Choi; G Dreyfuss
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

10.  Polyamine-mediated regulation of mouse ornithine decarboxylase is posttranslational.

Authors:  T van Daalen Wetters; M Macrae; M Brabant; A Sittler; P Coffino
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.